首页> 美国卫生研究院文献>The Journal of Pediatric Pharmacology and Therapeutics : JPPT >Oral Absorption of Enteral Vancomycin in a Child with Clostridium difficile Colitis and Renal Impairment
【2h】

Oral Absorption of Enteral Vancomycin in a Child with Clostridium difficile Colitis and Renal Impairment

机译:小儿难辨梭状结肠炎和肾功能不全患儿口服万古霉素的口服吸收

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Vancomycin is a glycopeptide antibiotic that is used by the enteral route for the treatment of Clostridium difficile infections and is not thought to be absorbed into the systemic circulation. We report on a 2-year-old, 12.5-kg patient with confirmed C difficile colitis and renal insufficiency that was treated with 125 mg of enteral vancomycin (10 mg/kg); the patient developed measurable systemic concentrations as high as 17.8 mg/L. However, as the patient's colitis began to improve, the serial vancomycin concentrations reflected little to no continued absorption of vancomycin. A review of the literature regarding this rare phenomenon is discussed.
机译:万古霉素是一种糖肽抗生素,可通过肠胃途径用于治疗艰难梭菌感染,并且认为不会吸收到全身循环中。我们报道了一名2岁,体重12.5公斤的确诊为艰难梭菌性结肠炎和肾功能不全的患者,接受125毫克肠万古霉素(10毫克/千克)的治疗;患者体内可测量的全身浓度高达17.8 mg / L。然而,随着患者结肠炎的开始好转,万古霉素的系列浓度反映出万古霉素的持续吸收很少甚至没有。讨论了有关这种罕见现象的文献综述。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号